Afficher la couverture 'Production of infectious hepatitis C virus in tissue culture: a breakthrough for basic and applied research. | Zeisel, Mirjam, B.' en grand format
/5

0 avis

Production of infectious hepatitis C virus in tissue culture: a breakthrough for basic and applied research.

Archive ouverte

Zeisel, Mirjam, B. | Baumert, Thomas, F.

Edité par CCSD ; Elsevier -

International audience. Hepatitis C virus (HCV) is a major cause of posttransfusion and community-acquired hepatitis in the world [1]. The majority of HCV-infected individuals develop chronic hepatitis that may progress to liver cirrhosis and hepatocellular carcinoma. Treatment options for chronic HCV infection are limited and a vaccine to prevent HCV infection is not available [1]. The development of efficient antivirals and a vaccine has been hampered by the lack of an efficient tissue culture model for HCV infection.

Suggestions

Du même auteur

HCV entry and neutralizing antibodies: lessons from viral variants.

Archive ouverte | Zeisel, Mirjam, B. | CCSD

International audience. Evaluation of: Grove J, Nielsen S, Zhong J et al.: Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sens...

Clinical development of hepatitis C virus host-targeting agents

Archive ouverte | Zeisel, Mirjam, B. | CCSD

International audience. -

Tight junction proteins in gastrointestinal and liver disease

Archive ouverte | Zeisel, Mirjam, B. | CCSD

International audience. Over the past two decades a growing body of evidence has demonstrated an important role of tight junction (TJ) proteins in the physiology and disease biology of GI and liver disease. On one s...

Chargement des enrichissements...